Brett Guthrie

I appreciate our bipartisan approach to this hearing and believe this hearing is a great example of how the Energy and Commerce Committee works.

The coronavirus outbreak has shown us the true strength of American technology.

My own home State of Kentucky and city of Louisville is grappling with the tragic death of Breonna Taylor.

My home State of Kentucky has been grappling with the tragic death of Breonna Taylor.

The Federal Trade Commission (FTC) and State Attorneys General are the cops on the beat when it comes to overseeing this industry.

Consumers should be able to clearly know what they are buying, who they're buying it from, and what is included in the price of the ticket.

Thank you, Chair DeGette, for holding this hearing.

The most recent data from the National Youth Tobacco Survey is alarming.

The marketing of e-cigarette products to children must stop, and youth access to e-cigarette products must be prevented.

I share your concern about youth vaping trends that have emerged in the United States in recent years.

The U.S. Surgeon General has called e-cigarette use by youth an epidemic and warned that it threatens decades of progress towards ensuring that fewer young people use tobacco.

We are cooperating closely with their criminal investigation teams.

We believe this authority is important to protect the integrity of the supply chain.

We appreciate the leadership of Representatives Guthrie and Engel on this issue.

I was proud to introduce three bipartisan bills today.

The Safeguarding Therapeutics Act introduced by Representative Brett Guthrie will protect against counterfeit medical devices.

Congress needs to continue supporting the states, and this Committee needs to continue conducting oversight of these critical issues.

The good news is that each state testifying before us today has seen a decrease in their overdose death rates.

This hearing is a critical opportunity for us to check in with the states, those that are on the front lines battling the nation's opioid epidemic.

Our local communities are suffering. On average, 130 Americans die every day from an opioid overdose.

I look forward to working with my colleagues to advance bipartisan reform that will actually lower drug prices while preserving innovative research.

I am disappointed that this week we are going to go through--pursue partisan legislation on the floor instead of bipartisan policies that have broad support.

The adequacy of FDA's oversight of the U.S. drug supply has been a longstanding issue for this committee.

Thank you, Chair DeGette, for holding this very important hearing.

I appreciate the administration's commitment to improving our flu preparedness.